Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Merit Medical Sys (MMSI)
Merit Medical Sys (MMSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,682,311
  • Shares Outstanding, K 57,494
  • Annual Sales, $ 1,151 M
  • Annual Income, $ 74,520 K
  • 60-Month Beta 1.00
  • Price/Sales 4.04
  • Price/Cash Flow 18.55
  • Price/Book 3.97
Trade MMSI with:

Options Overview Details

View History
  • Implied Volatility 14.83% ( -0.37%)
  • Historical Volatility 23.85%
  • IV Percentile 0%
  • IV Rank 14.34%
  • IV High 57.74% on 06/14/22
  • IV Low 7.65% on 11/21/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 148
  • Open Int (30-Day) 237

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.76
  • Number of Estimates 5
  • High Estimate 0.79
  • Low Estimate 0.74
  • Prior Year 0.73
  • Growth Rate Est. (year over year) +4.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.60 +2.31%
on 04/27/23
85.39 -4.62%
on 05/09/23
+3.77 (+4.85%)
since 04/26/23
3-Month
65.21 +24.88%
on 03/10/23
85.39 -4.62%
on 05/09/23
+10.78 (+15.26%)
since 02/24/23
52-Week
50.46 +61.40%
on 07/13/22
85.39 -4.62%
on 05/09/23
+20.65 (+33.97%)
since 05/26/22

Most Recent Stories

More News
Revvity's (PKI) Q1 Earnings Top, '23 View Below Expectations

Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.

CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
PKI : 115.24 (-0.91%)
MMSI : 81.44 (+0.61%)
Fresenius Medical (FMS) Q1 Earnings and Revenues Beat Estimates

Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.

CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
FMS : 21.58 (-1.15%)
MMSI : 81.44 (+0.61%)
Masimo (MASI) Q1 Earnings Surpass Estimates, Margins Down

Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.

CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
MASI : 157.35 (-0.39%)
MMSI : 81.44 (+0.61%)
DaVita (DVA) Tops Q1 Earnings Estimates, Ups FY23 EPS View

DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.

DVA : 94.28 (-0.82%)
CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
MMSI : 81.44 (+0.61%)
Shockwave Medical (SWAV) Q1 Earnings Top, Revenues Surge Y/Y

Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
MMSI : 81.44 (+0.61%)
SWAV : 280.67 (+0.70%)
McKesson (MCK) Q4 Earnings Beat Estimates, U.S. Sales Strong

McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.

CAH : 82.83 (-2.21%)
ABC : 168.41 (-1.03%)
MCK : 387.95 (-1.88%)
MMSI : 81.44 (+0.61%)
OPKO Health (OPK) Q1 Earnings and Revenues Top Estimates

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall first-quarter results reflect soft performances.

ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
MMSI : 81.44 (+0.61%)
OPK : 1.4100 (-0.70%)
QuidelOrtho (QDEL) Q1 Earnings Top Estimates, FY23 View Revised

Despite solid performances by the Labs segment and China region, QuidelOrtho (QDEL) reports soft overall top-line results in first-quarter 2023.

ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
MMSI : 81.44 (+0.61%)
QDEL : 85.54 (+0.97%)
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised

BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal second quarter.

BDX : 241.12 (-0.27%)
ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
MMSI : 81.44 (+0.61%)
Chart of the Day: Merit Medical Systems - Strong Buy Sentiment

The Chart of the Day belongs to the healthcare company Merit Medical Systems (MMSI) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

MMSI : 81.44 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional...

See More

Key Turning Points

3rd Resistance Point 83.12
2nd Resistance Point 82.49
1st Resistance Point 81.97
Last Price 81.44
1st Support Level 80.82
2nd Support Level 80.19
3rd Support Level 79.67

See More

52-Week High 85.39
Last Price 81.44
Fibonacci 61.8% 72.05
Fibonacci 50% 67.92
Fibonacci 38.2% 63.80
52-Week Low 50.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar